These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14557175)

  • 61. Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation.
    Marucci L; Ancukiewicz M; Lane AM; Collier JM; Gragoudas ES; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):842-6. PubMed ID: 20472356
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma.
    Schmittel A; Bechrakis NE; Martus P; Mutlu D; Scheibenbogen C; Bornfeld N; Foerster MH; Thiel E; Keilholz U
    Eur J Cancer; 2004 Nov; 40(16):2389-95. PubMed ID: 15519510
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comparison of prognostic covariates for uveal melanoma.
    Gamel JW; McCurdy JB; McLean IW
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1919-22. PubMed ID: 1582798
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Uveal malignant melanoma in Israel (1970-1989)].
    Shargal Y; Pe'er J
    Harefuah; 1995 Nov; 129(10):369-74, 448. PubMed ID: 8647537
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Eye-wall resection.
    Char DH; Miller T; Crawford JB
    Trans Am Ophthalmol Soc; 2000; 98():153-9; discussion 159-61. PubMed ID: 11190019
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gamma-knife-based stereotactic radiosurgery for uveal melanoma.
    Fakiris AJ; Lo SS; Henderson MA; Witt TC; Worth RM; Danis RP; Des Rosiers PM; Timmerman RD
    Stereotact Funct Neurosurg; 2007; 85(2-3):106-12. PubMed ID: 17228176
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The P-32 radioisotope test in uveal melanoma].
    Mondelski S; Pytlarz E; Neumann B
    Klin Oczna; 1982 Nov; 84(11):361-3. PubMed ID: 7183820
    [No Abstract]   [Full Text] [Related]  

  • 68. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
    Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
    Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic associations of insulin-like growth factor-1 receptor in primary uveal melanoma.
    Al-Jamal RT; Kivelä T
    Can J Ophthalmol; 2011 Dec; 46(6):471-6. PubMed ID: 22153631
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The use of radioactive phosphorus (32P) in the diagnosis of ocular tumors.
    Goldberg B; Kara GB; Previte LR
    Am J Ophthalmol; 1980 Dec; 90(6):817-28. PubMed ID: 7446669
    [TBL] [Abstract][Full Text] [Related]  

  • 72. American Joint Committee on Cancer Classification of Uveal Melanoma (Anatomic Stage) Predicts Prognosis in 7,731 Patients: The 2013 Zimmerman Lecture.
    Shields CL; Kaliki S; Furuta M; Fulco E; Alarcon C; Shields JA
    Ophthalmology; 2015 Jun; 122(6):1180-6. PubMed ID: 25813452
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study.
    Arzu Yaşar H; Turna H; Esin E; Murat Sedef A; Alkan A; Oksuzoglu B; Ozdemir N; Sendur MN; Sezer A; Kılıckap S; Utkan G; Akbulut H; Celik I; Abalı H; Urun Y
    J Oncol Pharm Pract; 2020 Mar; 26(2):267-272. PubMed ID: 30924738
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Unsuspected and misdiagnosed posterior uveal melanoma following enucleation and evisceration in Ottawa-Gatineau.
    Brownstein S; Jastrzebski A; Saleh S; Jordan DR; Gilberg SM; Leonard BC; Hurley BR
    Can J Ophthalmol; 2018 Apr; 53(2):155-161. PubMed ID: 29631828
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The diagnosis of uveal malignant melanomas in eyes with opaque media.
    Shields JA; McDonald PR; Leonard BC; Canny CL
    Am J Ophthalmol; 1977 Jan; 83(1):95-105. PubMed ID: 835673
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic value of apoptosis inducing factor in uveal melanoma.
    Krasnik V; Furdova A; Svetlosakova Z; Kobzova D; Gergisakova H; Feketeova L; Svetlosak M; Barta A; Babal P
    Neoplasma; 2017; 64(2):262-268. PubMed ID: 28043154
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma.
    Seddon JM; Albert DM; Lavin PT; Robinson N
    Arch Ophthalmol; 1983 Dec; 101(12):1894-9. PubMed ID: 6651594
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The prognostic significance of c-myc oncogene expression in uveal melanoma.
    Chana JS; Cree IA; Foss AJ; Hungerford JL; Wilson GD
    Melanoma Res; 1998 Apr; 8(2):139-44. PubMed ID: 9610866
    [TBL] [Abstract][Full Text] [Related]  

  • 79. External Validation of the Liverpool Uveal Melanoma Prognosticator Online.
    DeParis SW; Taktak A; Eleuteri A; Enanoria W; Heimann H; Coupland SE; Damato B
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6116-6122. PubMed ID: 27835710
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostication of metastatic death in uveal melanoma patients: A Markov multi-state model.
    Eleuteri A; Taktak AFG; Coupland SE; Heimann H; Kalirai H; Damato B
    Comput Biol Med; 2018 Nov; 102():151-156. PubMed ID: 30278339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.